Edwards Lifesciences Corporation

EW Healthcare · Medical Devices
Delayed 15 min
Last close
$91.18
Jun 29, 2026
52-week range
$72.30 — $92.88
-2% from high
Market cap
52.5B
Diluted basis
Dividend yield
No dividend declared
P/E
49.3
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral
RED DEEP / 100
Composite Health
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

Edwards Lifesciences Corporation’s most recent 10-Q for the period ended March 31, 2026, is notable for what it explicitly states has not changed. Item 7, Management’s Discussion and Analysis, refers readers to the prior 2025 10-K, asserting no significant changes from the information discussed therein regarding financial condition and results of operations. Similarly, for market risks, the filing states “no material changes” from the prior annual report’s disclosures on interest rate risk, foreign currency risk, credit risk, and concentrations of risk. This brevity suggests a period of relative stability, or at least one without new material developments requiring extensive quarterly elaboration.

The forensic accounting metrics for this filing are uniformly “not available,” which means the Beneish M-Score (Beneish’s 1999 eight-ratio earnings-manipulation detector), Altman Z″ (Altman’s 1968 bankruptcy-distress index), Piotroski F-Score (Piotroski’s 9-point 2000 fundamental strength scan), and Fog Index (Gunning’s 1952 readability score; 12 = newspaper, 18+ = obfuscatory) cannot be assessed from the provided excerpts. While the absence of these scores prevents a quantitative assessment of potential accounting red flags or fundamental strength, it does not, in itself, signal distress. It simply means this particular filing’s excerpts do not provide the necessary data for computation.

Item 1A, Risk Factors, begins with a “NOTE REGARDING FORWARD-LOOKING STATEMENTS,” a common but important section. This note clarifies that the report contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, and that the company intends these statements to be covered by the safe harbor provisions of such Acts. This boilerplate serves as a reminder that any projections or future-oriented comments within the filing are subject to inherent uncertainties and should be interpreted with caution, a standard practice for managing investor expectations.

This filing, therefore, primarily communicates continuity. It tells us that management perceives no material shifts in the company’s financial condition or risk profile since the last annual report. What it cannot tell us, due to the limited excerpts and unavailable forensic scores, is whether there are any subtle accounting trends, underlying financial weaknesses, or strengths that might not be explicitly flagged as “material changes.” A comprehensive view would require the full 10-Q and the referenced 10-K to evaluate the actual financial statements and the detailed risk factors.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • May 6, 2026
    10-Q
    Quarterly report (2026-03-31)Period: 2026-03-310
    Read →
  • May 4, 2026
    8-K
    Material event (2026-05-02)### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0
    Read →
  • Apr 23, 2026
    8-K
    Material event (2026-04-23)No specific items found in 8-K.0
    Read →
  • Mar 26, 2026
    DEF 14A
    Proxy statement (2026-05-07)0
    Read →
  • Feb 25, 2026
    10-K
    Annual report (2025-12-31)Period: 2025-12-310
    Read →
  • Feb 10, 2026
    8-K
    Material event (2026-02-10)No specific items found in 8-K.0
    Read →
Member feature · Custom Q&A
Ask anything about EW's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →